OKYO Pharma to Present at OIS XV in San Diego

OKYO Pharma to Present at OIS XV in San Diego

by | 18th November 2025 | News

London and New York, NY, November 18, 2025. OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe...